Elizabeth (Nicki) Bush is the Director and Global Head of the Patient-Focused Outcomes Center of Expertise at Eli Lilly and Company, responsible for the design and implementation of patient-centered measurement strategies to support drug development efforts across Lilly’s portfolio.  In this capacity, she and her team advise drug development teams in the selection, modification and development of  clinical outcome assessments (COAs) for use in clinical trials and other research studies, and utilize mixed methods approaches to evaluate the measurement properties of COAs and aide in interpretation of the resultant data.

Nicki has held research and leadership positions in the patient-centered measurement field in both consultancy and industry for over ten years.  During this time, she has collaborated with partners in industry, regulatory agencies, and academia and held the position of Industry Co-Director of the PRO Consortium from 2016-2018.  Her previous experience includes behavioral research and program evaluation. Ms. Bush earned her BA in the liberal arts (philosophy and history of mathematics and science) from St. John’s College and her master’s degree in epidemiology from the Johns Hopkins Bloomberg School of Public Health.